key: cord-0941964-o4z68l8j
authors: Chernyavskiy, P.; Richardson, J. W.; Ratcliffe, S. J.
title: COVID-19 vaccine uptake in United States counties: geospatial vaccination patterns and trajectories towards herd immunity
date: 2021-05-31
journal: nan
DOI: 10.1101/2021.05.28.21257946
sha: 576af9b562bd70f2924677cc04b9b615ec88de69
doc_id: 941964
cord_uid: o4z68l8j

Following the COVID-19 pandemic, safe and effective vaccines were developed and authorized for use in the general population. Studying factors that encourage community acceptance of these vaccines is needed to prevent proliferation of SARS-CoV-2 variants, to safely relax local restrictions, and to return to pre-pandemic living conditions. To our knowledge, United States (US) county-level disparities in vaccination are yet to be investigated. Our data span February - May 2021 across 3138 US counties. We consider percentage of residents with at least one dose of an authorized COVID vaccine as the outcome. Spatio-temporal models were used to determine associations of vaccination rates with time-fixed and time-varying covariates. Spatial variability was modelled via Conditional Auto-regressive models; county trajectories over time were specified using random slopes. Greater vaccination rates occur in counties with older residents, high educational attainment, and high proportion of minority residents. Vaccination rates change with COVID risk metrics, suggesting continued slowing of vaccine uptake due to decreasing incidence and infection rates. County effects reveal strong regional patterns in average vaccination rates and trajectories. Although local herd immunity can be expected in August 2021 for counties with typical uptake rates, these counties are clustered in relatively few areas of the country.

The Coronavirus Disease (COVID)-19 pandemic has been a defining generational event, with no country, region, or municipality spared. Following the rapid development of several safe and effective vaccines 1-3 , encouraging broad community acceptance has become crucially important 4, 5 . Although some progress towards population herd immunity is expected by summer of 2021 6 , it is yet unclear how the increasing prevalence of novel SARS-CoV-2 variants 7 , the incidence of break-through infections 8 , and levels of vaccine hesitancy will affect this timeline [9] [10] [11] .

Early research around COVID vaccine acceptance has been prospective, with many findings based on surveys about a potential vaccine [12] [13] [14] [15] , and/or limited to a population of healthcare workers 16, 17 . Recent work has targeted the general population to investigate associations between demographics and attitudes towards the vaccine. Evidence from the United Kingdom (UK) suggests that vaccine hesitancy is higher among younger, lower income, lower education, and non-White minority ethnic groups 18 . The same survey also suggested associations with perceived risk from COVID, reliance on information obtained via specific social media platforms, and levels of trust in government and public health officials. Latent psychological factors, such as religiosity, social dominance, cognitive reflection, and altruism have also been associated with COVID vaccine attitudes in the UK and Ireland 19 .

Besides population characteristics, there is strong evidence that political ideology influences vaccine attitudes. Survey responses from France indicate that the odds of acceptance were highest when respondents identified with the governing party 20 . Recent polls 21, 22 from the US also found stark differences by political affiliation: Democrats -the current governing party -as well as individuals who identified as "liberal" reported being more accepting than Republicans and individuals who identified as "conservative". However, differences by race/ethnicity (White vs. Black) were comparatively small relative to differences by political ideology and data on racial/ethnic differences from the UK 23 . The extent of racial/ethnic disparities in the US is yet unknown because demographics are available for only 55% of Americans who have received at least one dose. The majority of this group is comprised of White (64%) individuals, followed by Hispanic (12%), Black (9%), and Asian (5%) 24 . Further, documented experimentation at the hands of researchers in communities of color could fuel vaccine hesitancy in the US 25 .

The recent US poll 21 found that political affiliation is additionally responsible for the variable levels of trust in health experts, broadcast news media, and elected officials with respect to vaccine information. The lack of consensus around credible sources has fueled misinformation around the vaccine, including false claims that vaccines: are linked to cellular networks, are a vehicle to implant microchips, are able to modify the human genome, or that the development process was rushed 26 . In the case of Janssen (Johnson & Johnson), religiosity may influence vaccine uptake given its designation as "morally compromised" 27 . Not surprisingly, exposure to misinformation is harmful to acceptance: an experiment conducted on UK and US participants showed that misinformation reduced intent to get vaccinated; however, women, ethnic minorities, and low-income participants exhibited greater resistance 28 . Additionally, misinformation contributes to fear around vaccination, which in-turn reduces willingness to be vaccinated 22 .

Although US vaccination figures are available through several reliable sources (e.g., CDC 29 , Johns Hopkins Coronavirus Resource Center 30 ), there has been a dearth of studies at the sub-state level. Here, we focus on disparities in vaccination rates among US counties. We investigate geographic disparities in average vaccination rates, as well as disparities in the trends . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint of uptake over time, which we call vaccination trajectories. We partition geographic disparities into "expected", which are attributable to socio-demographic and disease risk factors (e.g., age, educational attainment, COVID incidence rates), and "latent", which are a function of unobserved or unobservable factors (e.g., political affiliation, levels of trust in officials). In doing so, we identify counties that are over-and under-performing based on their known population characteristics. The estimated vaccination trajectories are then used to forecast when vaccination rates for representative counties are expected to reach a herd immunity threshold of 70%.

Consensus around herd immunity for COVID has not yet been established; however, the threshold used in this article is among the plausible levels cited by the Mayo Clinic 31 and the Kaiser Foundation 32 . Finally, we demonstrate that our predictive model is accurate up to an 8-

week-ahead forecast, making our predictions useful for modifying within-state vaccine distribution, adjusting vaccination centers' staffing needs, and informing investments in local interventions.

Vaccination data were downloaded from the COVID Act Now Application Programming Interface 33 , using an access key obtained in January 2021. COVID Act Now is a nonprofit organization that aggregates data reported by the US Department of Health and Human Services, CDC, and online dashboards for individual states and counties. Data were available for all 50 US states and the District of Columbia, which comprised 3138 (99.9%) counties covering 98.7% of the 2018 US population. Daily vaccinations for each county were aggregated into calendar weeks to avoid day-of-week effects and to reduce noise due to reporting delays and data revisions that may take place within the week. Because county-level data for all 50 states became available only on May 1, our data span the most recent 13 weeks from February 21 st through May 16 th .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Time-varying metrics on COVID incidence rates per 100,000 residents, estimated infection rates (R t ), and test positivity rates, were obtained from the COVID Act Now API and aggregated into calendar weeks to match the temporal scale of analysis. Mortality rates were available but were excluded due to high correlation with incidence rates.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. :

is the probit link function and ߶ is the Beta regression scale parameter.

In equation (1) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) .

We evaluated several space-time models and selected one using well-established metrics:

WAIC and the logarithmic score (LS). We provide more details of our statistical modeling in Supplementary Materials, including: an overview of INLA estimation, prior distributions used, and results from a predictive cross-validation exercise with up to an 8-week-ahead forecast.

Diagnostics and parameter estimates for the selected model are shown as part of Supplementary

Materials. Additionally, we provide an interactive version of all maps in this article at the following publicly accessible repository (https://github.com/pchernya/Covid_Vaccine_US) that will be updated each week, along with our projections, as new data become available.

Data from more counties became available over time ( Figure 1 ; Supplementary Figure 1) ; these covariates remained in the statistical model together.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Counties with high vaccination rates tended to be older, college-educated communities, with high proportions of minority residents, especially Hispanic and Native American individuals ( Figure 2) . Alternatively, counties with low vaccination rates tended to have low educational attainment and high proportions of children under age 18. Among the time-varying metrics, counties with higher COVID incidence and higher infection rates tended to have higher vaccination rates, whereas counties with high test positivity rates tended to have lower rates.

Latent county effects and vaccination trajectories reveal strong regional patterns. The majority of Table   1 ). The CDC SVI suggests that communities in Alaska face challenges related to housing and transportation and minority and language status. Both counties in North Dakota have favorable rankings across the four SVI themes. The county in Virginia stands out due to its minority and language status, whereas the county in New Hampshire stands out due to its household composition and disability status, as well as its housing and transportation status. (Table 2 ). These counties tend to have favorable socioeconomic status, household composition and disability rankings, as well as housing and transportation rankings, with notable exceptions in Alaska and Vermont. Manassas Park City in Virginia stands out because it is also the most over-performing county in Table 1 .

To illustrate the implications of the disparity in vaccination trajectories, we forecasted vaccination rates for counties in the top 10%, top 25%, median, bottom 25%, and bottom 10% of the estimated trajectories distribution (Figure 4 ). Using 70% as the herd immunity threshold, counties in the top 10% and top 25% are forecasted to reach herd immunity by the week of June The forecast for the end of July 2021 ( Figure 5A) shows that modal vaccination rates are expected to be between 40% and 60%, with some areas as low as 20%. The herd immunity . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

To our knowledge, our article describes the first predictive spatio-temporal analysis of US county COVID vaccination uptake. We identified demographic factors and disease risk metrics that explain variability in county vaccination rates and determined counties that over-and underperform their demographics due to unobserved local factors. Geographic disparities in average vaccination rates and vaccination trajectories were stark, with the latter revealing localized favorable trends concentrated in metropolitan areas. Our forecasts show a growing divide between high-uptake and low-uptake counties: those in the top 25% of estimated vaccination trajectories are expected to reach a 70% herd immunity threshold by the end of July 2021, but those in bottom 25% only by the first week of 2022. Although the median trajectory counties are expected to reach herd immunity by the start of the Fall 2021 school year, these counties are generally concentrated in only a few areas of the country and so the next school year may be adversely affected across a large portion of the US.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021.

Intuitively and in-line with UK data 18 , we show that older and more educated communities have had higher vaccine uptake to date, whereas younger and less educated communities have had lower uptake. This is not surprising given that vaccinations first available to older adults and the use of online sign-up systems are barriers to low-income and communities of color 48,49 . Additionally, county vaccination rates change with COVID risk levels in the community as counties with higher incidence and infection rates have higher vaccination rates, on average. This suggests that greater visibility of current community risk via local media channels may be beneficial.

Less intuitively, we offer evidence that counties with large minority populations, especially Hispanic, Native, and Black residents, have higher vaccination uptake. This result might be attributed to health officials' efforts to reach minority populations early with targeted messaging 50 plus the fact that minorities have had a disproportionate number of cases and deaths during the pandemic. Consistent with greater vaccination rates among residents who perceive greater risk 19 , minority communities may be more accepting of the COVID vaccine than suggested by prior surveys 21 .

Our finding of negative association between test positivity and vaccination rates may also be unintuitive. In our view, this variable acts as a proxy for testing behavior as opposed to a measure of community risk. Counties with high test positivity may signal that it is difficult to obtain a test, or residents tend to get tested only after symptoms have developed. This may also reflect the perception that a positive test indicates one will become immune after several weeks and so residents are less likely to obtain a vaccination.

Our ability to score each county as over-or under-performing their known characteristics can inform vaccine redistribution efforts within-and between-states. Our models were accurate . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint within a 4-weeks-ahead forecast and may still be useful up to an 8-week-ahead forecast.

Predicted vaccination rates will be updated on a weekly basis on this website (https://github.com/pchernya/Covid_Vaccine_US). In addition to vaccine redistribution, these can inform local reopening policies, and staffing levels at vaccination sites.

Our article has several important limitations. First, our data are ecological in nature, only available at the level of county. Thus, we cannot use our analysis to infer behavior for any individual resident. Second, while the CDC reports making reasonable efforts to determine county of residence, certain reporting practices, such as reporting through retail pharmacies, federal facilities, or long-term care facilities may result in low vaccination coverage data. This has potential to add noise to our vaccination maps, especially in areas of high resident mobility or vaccination tourism. Third, although we produce accurate short-term forecasts, unforeseen factors such as discoveries of major adverse reactions, geopolitical events, natural disasters, and logistical breaks in the supply chain cannot be incorporated into our forecast, although these will certainly affect vaccination uptake. In fact, our longer-term forecast should only be considered as a counter-factual scenario if current trends hold.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 16, 2021 . Each panel is labelled using a two-letter US state abbreviation. Each point plotted represents data for a county at the end of a given week. Some overplotting may occur; this may lead to an appearance of darker colored points.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint Figure 2 . Estimated coefficients of time-fixed and time-varying US county effects from the selected spatio-temporal Beta regression model with a probit link, sorted by absolute magnitude. All covariates were centered and scaled prior to analysis. Vaccination data cover February 21, 2021 through May 16, 2021.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint Figure 3 . Standardized time-averaged joint (spatial + unstructured) county effects (A) and standardized deviations from the typical trajectory (B). Values > 0 indicate a county is overperforming its known characteristics; values < 0 indicate a county is under-performing its known characteristics. Diagonal hatch pattern indicates missing data, which occurs in Alaska, Arizona, and South Dakota. Vaccination data cover February 21, 2021 through May 16, 2021.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint Figure 5 . Forecasted percentage of residents with at least one dose by US county for the week ending on July 31 (July 25 -31) (A) and estimated probability of local herd immunity, i.e. Pr(prediction > 70%) (B). Diagonal hatch pattern indicates missing data, which occurs in Alaska, Arizona, and South Dakota. Forecast is based on data from February 21, 2021 through May 16, 2021.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 31, 2021. ; https://doi.org/10.1101/2021.05.28.21257946 doi: medRxiv preprint

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

Covid-19: Where are we on vaccines and variants?

Ensuring uptake of vaccines against SARS-CoV-2

Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. The Lancet Infectious Diseases

Is herd immunity closer than we think?

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet Infectious Diseases

COVID-19 and vaccine hesitancy: A longitudinal study

Unraveling Attributes of COVID-19 Vaccine Hesitancy in the U.S.: A Large Nationwide Study. medRxiv

Vaccine hesitancy: the next challenge in the fight against COVID-19. European journal of epidemiology

A global survey of potential acceptance of a COVID-19 vaccine. Nature medicine

COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries

The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue

Cross-sectional Assessment of COVID-19 vaccine acceptance among health care workers in Los Angeles

Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. International journal of nursing studies

Coronavirus conspiracy suspicions, general vaccine attitudes, trust, and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic

Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. The Lancet Public Health

An Uncertain Public-Encouraging Acceptance of Covid-19 Vaccines

The COVID-19 Vaccine Is Here-Now Who Is Willing to Get It?. Vaccines

Covid-19 vaccine hesitancy among ethnic minority groups

Latest Data on COVID-19 Vaccinations Race/Ethnicity

Medical Apartheid: The dark history of medical experimentation on Black Americans from colonial time to the present

Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. EClinicalMedicine

Catholic leaders voice moral concerns about Johnson & Johnson vaccine. NPR [Internet

Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature human behaviour

COVID-19 Vaccination | CDC

Hopkins Coronavirus Resource Center

Johns Hopkins Coronavirus Resource Center

Herd immunity and COVID-19 (coronavirus): What you need to know

Can Vaccination and Infection Rates Add Up to Reach Covid Herd Immunity?

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers -Eight U.S. Locations

Simplify the Creation of Choropleth Maps in R

USDA ERS -Atlas of Rural and Small-Town America

CDC's Social Vulnerability Index (SVI)

Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations

R: A Language and Environment for Statistical Computing

The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity. The Lancet

Drinking patterns in US counties from 2002 to 2012. American journal of public health

County-level trends in suicide rates in the US

Assessing differential impacts of COVID-19 on black communities

Beta regression for modelling rates and proportions